Exozymes (EXOZ) Other Accumulated Expenses (2023 - 2025)

Exozymes (EXOZ) has reported Other Accumulated Expenses for 3 consecutive years, with $5330.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Accumulated Expenses fell 97.02% year-over-year to $5330.0; the TTM figure through Dec 2025 stood at $5330.0 (down 97.02% YoY), while the FY2025 annual figure was $5330.0, down 97.02% from the prior year.
• Other Accumulated Expenses slipped to $5330.0 in Q4 2025 per EXOZ's latest filing, from $17085.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $3.4 million in Q3 2024 and bottomed at $5330.0 in Q4 2025.
• Historically, Other Accumulated Expenses has averaged $699385.7 across 3 years, with a median of $157339.0 in 2024.
• Annual changes were most pronounced in 2024 — Other Accumulated Expenses sank 59.79% — and 2025, when it sank 99.5%.
• Exozymes' Other Accumulated Expenses stood at $445128.0 in 2023, then sank by 59.79% to $178966.0 in 2024, then plunged by 97.02% to $5330.0 in 2025.
• Business Quant data shows EXOZ's Other Accumulated Expenses at $5330.0 in Q4 2025, $17085.0 in Q3 2025, and $135712.0 in Q1 2025.